US91307C1027
US91307C1027
United Therapeutics Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.182.700.000 | 2.877.400.000 | 10.6% |
| Cost of Revenue | 384.400.000 | 309.700.000 | 24.1% |
| Gross Profit | 2.798.300.000 | 2.567.700.000 | 9.0% |
| 1.281.100.000 | 1.119.600.000 | 14.4% | |
| Operating Income | 1.517.200.000 | 1.448.100.000 | 4.8% |
| Pretax Income | 1.713.900.000 | 1.539.000.000 | 11.4% |
| Net Income Common Stockholders | 1.334.700.000 | 1.195.100.000 | 11.7% |
| -- | -- | -- | |
| -- | -- | -- |